Structural requirements of peptide and MHC for DR(alpha, beta 1*0401)-restricted T cell antigen recognition

J Immunol. 1995 Aug 15;155(4):1951-63.

Abstract

We identified functionally important regions of the DR(alpha, beta 1*0401) peptide binding site and present a model of bound peptide. DR(alpha, beta 1*0401)-restricted T cell recognition and peptide binding of Mycobacterium leprae (ML) peptide 38-50 and overlapping peptides from the 18-kDa heat-shock protein were analyzed. ML38-50 is unusual in its restricted binding pattern, binding to only one of five DR4 subtypes and no other DR molecules tested. Amino acid substitutions were introduced into ML38-50 and the DR(alpha, beta 1*0401) peptide binding site at positions likely to influence peptide-MHC or peptide- or MHC-TCR interactions. Peptide binding, T cell proliferation, and computer modeling studies suggest that residues 39F, 42E, and 44D of ML38-50 interact with pockets 1, 4, and 6, respectively, of the peptide binding site. Only DR(alpha, beta 1*0401) substitutions at residues in pockets 4 or 7 prevented binding of ML38-50, while multiple substitutions at other positions negatively affected its T cell recognition. In contrast, T cell recognition of some high affinity ML peptides that overlapped ML38-50, and contained N-terminal extensions, was only abolished with pocket 4 substitutions. An inverse correlation of peptide affinity for DR(alpha, beta 1*0401) with negative effects of MHC substitutions on T cell recognition of the overlapping ML peptides was observed. Thus, some regions, such as pocket 4, dominantly influence T cell recognition of multiple DR(alpha, beta 1*0401)-binding peptides. However, each DR(alpha, beta 1*0401)-binding peptide appears to have unique properties that determine the outcome of its MHC-peptide interactions and the relative importance of other polymorphic pockets.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Autoimmune Diseases / immunology
  • Binding Sites
  • HLA-DR Antigens / chemistry*
  • HLA-DR Antigens / metabolism
  • Humans
  • Molecular Sequence Data
  • Mycobacterium leprae / immunology
  • Peptide Fragments / metabolism*
  • Protein Structure, Secondary
  • Receptors, Antigen, T-Cell / metabolism*
  • Structure-Activity Relationship
  • T-Lymphocytes / immunology*
  • Vaccines / immunology

Substances

  • HLA-DR Antigens
  • Peptide Fragments
  • Receptors, Antigen, T-Cell
  • Vaccines